Press Releases

SeekIn Inc. presents three studies at the 67th American Society of Hematology (ASH) Annual Meeting in Orlando

December 8, 2025 · Press Releases

Orlando, Florida — December 8, 2025 — SeekIn Inc. announced that three clinical studies featuring...

SeekIn Showcases Cost-Effective Two-Step Multi-Cancer Screening Strategy and Pan-Cancer Treatment Monitoring Breakthrough at CNAPS 2025

December 4, 2025 · Press Releases

Hong Kong, China – December 4, 2025 - SeekIn Inc., a biotech company specializing in blood-based...

Product Launch | OncoGraph: A New Era of Accessible Personalized Tumor Monitoring

November 27, 2025 · Press Releases

SeekIn Inc. announces the launch of OncoGraph, an innovative blood test designed to deliver...

OncoInv signs distribution agreement for OncoSeek® in El Salvador - SeekIn's partner OncoInv signs distribution agreement for OncoSeek® in El Salvador

November 27, 2025 · Media Resources

El Salvador - November 27, 2025 - OncoInv has signed a new distribution partnership with MaxBloch...

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer Early Detection at the 2025 Early Detection of Cancer Conference

October 20, 2025 · Press Releases

Portland, Oregon — October 20, 2025 — SeekIn Inc., a leader in liquid biopsy-based cancer...

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, Affordable AI Blood Test for Multi-Cancer Early Detection

October 9, 2025 · Press Releases

San Diego, USA — October 9, 2025 — SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn Expanding Lung Cancer Screening With Low-Cost Blood Test

October 7, 2025 · Media Resources

NEW YORK - October 7, 2025 - Bolstered by recent study results, cancer diagnostics firm SeekIn is...

LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

October 1, 2025 · Press Releases

San Diego, USA – October 1, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn’s OncoSeek® test Recognized in China’s Expert Consensus on Multi-Cancer Early Detection

August 8, 2025 · Press Releases

Shenzhen, China - August 7, 2025 - SeekIn Inc., a leading innovator in liquid biopsy-based cancer...

SeekIn Secures Five U.S. Trademarks for Breakthrough Cancer Diagnostic Tests, Capping Global IP Expansion

July 27, 2025 · Press Releases

San Diego, July 28, 2025 - SeekIn Inc., a leader in blood-based early cancer detection and...

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

July 3, 2025 · Media Resources

San Diego, July 2, 2025 -- A new prospective study published in BMC Cancer demonstrates that a...

Accelerating early cancer detection in Latin America: Biotecgen enters strategic partnership with OncoInv

June 18, 2025 · Media Resources

San Diego, June 18, 2025 -- Biotecgen (Colombia) and OncoInv (The Netherlands) have joined forces...

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

June 2, 2025 · Media Resources

San Diego, May 26, 2025 -- A groundbreaking study published in the Journal of Molecular...

SeekIn to Present Cancer Early Detection Technologies at the 2025 ASCO Annual Meeting

May 30, 2025 · Press Releases

CHICAGO, United States, May 30, 2025 - SeekIn Inc., a leader in blood-based cancer early...

From Non-Invasive Early Detection to Treatment Response Monitoring: SeekIn Presents Three Innovative Technologies at EUROMEDLAB 2025

May 20, 2025 · Press Releases

Brussels, Belgian - May 18-22, 2025 SeekIn Inc., a leader in blood-based cancer early detection...

2025 European Debut: SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at NKI Early Cancer Detection Conference

May 15, 2025 · Press Releases

Amsterdam, the Netherlands - May 14-15, 2025 SeekIn Inc., a leader in blood-based cancer early...

All Categories - SeekIn

SeekIn Inc. presents three studies at the 67th American Society of Hematology (ASH) Annual Meeting in Orlando

SeekIn Showcases Cost-Effective Two-Step Multi-Cancer Screening Strategy and Pan-Cancer Treatment Monitoring Breakthrough at CNAPS 2025

Product Launch | OncoGraph: A New Era of Accessible Personalized Tumor Monitoring

OncoInv signs distribution agreement for OncoSeek® in El Salvador - SeekIn's partner OncoInv signs distribution agreement for OncoSeek® in El Salvador

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer Early Detection at the 2025 Early Detection of Cancer Conference

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, Affordable AI Blood Test for Multi-Cancer Early Detection

SeekIn Expanding Lung Cancer Screening With Low-Cost Blood Test

LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

SeekIn’s OncoSeek® test Recognized in China’s Expert Consensus on Multi-Cancer Early Detection

SeekIn Secures Five U.S. Trademarks for Breakthrough Cancer Diagnostic Tests, Capping Global IP Expansion

SeekInClarity: Blood-Based Multi-Omics Test Offers Promising Advance in Monitoring Cancer Treatment Response

Accelerating early cancer detection in Latin America: Biotecgen enters strategic partnership with OncoInv

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

SeekIn to Present Cancer Early Detection Technologies at the 2025 ASCO Annual Meeting

From Non-Invasive Early Detection to Treatment Response Monitoring: SeekIn Presents Three Innovative Technologies at EUROMEDLAB 2025

2025 European Debut: SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at NKI Early Cancer Detection Conference

Longevity Medical Institute™ Integrates OncoSeek® to Launch One of Mexico's Most Advanced Cancer Screening Programs

BIOS and OncoInv have joined in partnership to bring cancer detection to Pakistan

SeekIn's Two-Step Multi-Cancer Early Detection Method May Reduce False Positives, Screening Costs

SeekIn Publishes A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection

SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.

Newsroom

SeekIn Inc. presents three studies at the 67th American Society of Hematology...

SeekIn Showcases Cost-Effective Two-Step Multi-Cancer Screening Strategy...

Product Launch | OncoGraph: A New Era of Accessible Personalized Tumor...

OncoInv signs distribution agreement for OncoSeek® in El Salvador - ...

SeekIn to Present Four New Studies Advancing Cost-Effective Multi-Cancer...

Large-scale Multi-Center Study Validates OncoSeek®: Transformative, ...